Placental tissue draws great interest as a source of cells for regenerative medicine because
of the phenotypic plasticity of many of the cell types isolated from this tissue. Furthermore …

Mesenchymal stem cells (MSCs) are multipotent adult stem cells present in all tissues, as
part of the perivascular population. As multipotent cells, MSCs can differentiate into different …

Despite a vast amount of different methods, protocols and cryoprotective agents (CPA), stem
cells are often frozen using standard protocols that have been optimized for use with cell …

Objective To review current evidence regarding umbilical cord blood counselling, collection,
and banking and to provide guidelines for Canadian health care professionals regarding …

Hematopoietic stem cell (HSC) transplantation is a well-established procedure for the
treatment of many blood related malignancies and disorders. Before transplantation, HSC …

In addition to its essential role in the development, nutrition and immunological tolerance of
the product of conception, human placenta is an important source of stem cells. Over the …

The reconstitution of adult stem cells may be a promising source for the regeneration of
damaged tissues and for the reconstitution of organ dysfunction. However, there are two …

BACKGROUND The total nucleated cell dosage of umbilical cord blood (UCB) is an
important factor in determining successful allogeneic hematopoietic stem cell transplantation …

The objective of the study was to evaluate the current standard practice of using volume and
total nucleated cell (TNC) count for the selection of cord blood (CB) units for …

Cryopreservation is the final step of stem cell production before the cryostorage of the
product. Conventional methods of adding cryoprotecting agents (CPA) into the cells can be …